Acta Scientific Cancer Biology (ASCB)(ISSN: 2582-4473)

Research Article Volume 4 Issue 10

About Extended Lymph-Node Dissection for Pancreatic Ductal Adenocarcinoma

Ramiz Bayramov

Professor at Department of Oncology, Azerbaijan Medical University, Baku, Azerbaijan

*Corresponding Author: Ramiz Bayramov, Professor at Department of Oncology, Azerbaijan Medical University, Baku, Azerbaijan.

Received: September 19, 2020; Published: September 29, 2020


Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive malignant tumors in the human organism and is the most prevalent neoplastic disease of the pancreas accounting for approximately 90% of all pancreatic malignancies. To date, pancreatic cancer is the seventh most common cause of cancer-related deaths worldwide. The incidence of PDAC demonstrates annual 5 - 6% absolute increase worldwide and is expected to rise further in the future.





Citation: Ramiz Bayramov. “About Extended Lymph-Node Dissection for Pancreatic Ductal Adenocarcinoma”. Acta Scientific Cancer Biology 4.11 (2020): 01-03.


Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US